Patents/Assignees

Genentech, Inc.

259 patents in portfolio

US11603373utility2023
TDO2 and IDO1 Inhibitors
0 cites
US11597776utility2023
Composition Comprising Antibody That Binds to Domain II of HER2 and Acidic Variants Thereof
0 cites
US11597761utility2023
Methods of Detecting Polyubiquitin Using Anti-polyubiquitin Antibodies
0 cites
US11591382utility2023
Expression of Fc-containing Proteins
0 cites
US11591345utility2023
Polymorphs and Solid Forms of (s)-2-((2-((s)-4-(difluoromethyl)-2-oxooxazolidin-3-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)amino)propanamide, and Methods of Production
0 cites
US11576979utility2023
Pyrrolobenzodiazepine Prodrugs and Antibody Conjugates Thereof
0 cites
US11576919utility2023
Treatment of Breast Cancer Using Combination Therapies Comprising an ATP Competitive AKT Inhibitor, a CDK4/6 Inhibitor, and Fulvestrant
0 cites
US11571506utility2023
Sterile Sealed Heterogeneous Medicament Delivery Device
0 cites
US11573226utility2023
Systems and Methods for Affinity Capillary Electrophoresis
0 cites
US11565054utility2023
Injection Monitoring Device with Delivery Signature
0 cites
US11566003utility2023
Isoquinolines as Inhibitors of HPK1
0 cites
US11560391utility2023
Sulfonylurea Compounds as Inhibitors of Interleukin-1 Activity
0 cites
US11555065utility2023
Anti-tau Antibodies and Methods of Use
0 cites
US11555076utility2023
Anti-mic Antibodies and Methods of Use
0 cites
US11547762utility2023
Methods for Preparing Antibody Drug Conjugates
0 cites
US11547701utility2023
Compounds and Compositions for the Inhibition of NAMPT
0 cites
US11542308utility2023
FLT3 Ligand Fusion Proteins and Methods of Use
0 cites
US11541187utility2023
Injection Monitoring Device
0 cites
US8343955utility2013
Benzoxazepin PI3K Inhibitor Compounds and Methods of Use
0 cites

← PreviousPage 13 of 13